Targeted cancer drugs are widely used because of their ability to inhibit specific proteins involved in cancer development with fewer side effects compared to chemotherapy drugs.
Moffitt Cancer Center researchers identify hidden target of ROS1 inhibitor lorlatinib
- Post author:
- Post published:October 16, 2023
- Post category:uncategorized